United Therapeutics Corporation

NASDAQ:UTHR

Biotechnology

Healthcare
$577.34 -3.27%

-$18.01 today

Market cap
$24.59B
Beta
0.57
P/E (TTM)
18.0
EPS (TTM)
$29.60
52W Low $272.12High $609.35

Volume 0.42M

Average 0.52M

UTHR Total Current Assets

All assets expected to be converted to cash or used up within one year.

United Therapeutics CorporationNASDAQ: UTHR

Total Current Assets · Q2 FY2026 · quarter ended Jun 2026

Total current assets falls 9.0% from a year ago

Total current assets stood at $3.48B at the end of Q2 FY2026, down 9.0% from a year earlier and up 21.3% from the prior quarter. Over 3 fiscal years it compounded at +3.1% a year.

Context

  • Total current assets amounted to 48.3% of total assets at the end of Q2 FY2026, down 0.1 pp from a year earlier.
  • Total current assets increased in 2 of the last 3 fiscal years.

What to watch

Whether total current assets keeps falling in the next quarterly balance sheet after a -9.0% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterJun 2026
$3.48B+21.3% QoQ
Last fiscal yearDec 2025
$3.7B-4.4% YoY
Year agoJun 2025
$3.83B-9.0% since
Total Current Assets past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-9.0%——
1 year-4.4%——
3-year CAGR+3.1%——
5-year CAGR——
10-year CAGR——

Total Current Assets history

USD · from the balance sheet

Latest · FY2025
3.7B USD
Year-over-year change
-4.4%
4-year CAGR
+12.4%

Total Current Assets vs competitors

How UTHR compares with its peers on the latest reported figures

  • UTHR's Jun 2026 total current assets of $3.48B is the highest of the 5 companies compared; the peer median is $535.58M.
  • Its year-over-year change of -9.0% is the 4th highest of 5, against a peer median of +76.8%.
  • Total current assets amounts to 48.3% of total assets for UTHR, versus a peer median of 80.8%.
UTHR Competitors Peer median
Total Current Assets for UTHR and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
UTHRUnited Therapeutics CorporationJun 2026$3.48B -9.0%+3.1%48.3%
INSMInsmed IncorporatedJun 2026$1.63B -21.5%+12.1%77.7%
TVTXTravere Therapeutics, Inc.Sep 2026$633.45M +70.7%-3.5%74.7%
LQDALiquidia CorporationJun 2026$437.71M +123.8%+24.1%83.9%
IKTInhibikase Therapeutics, Inc.Mar 2026$172.18M +82.8%+94.8%99.3%
Peer median (excluding UTHR) $535.58M+76.8%+18.1%80.8%

Competitors are the stored peer set for UTHR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents894.8M961.2M1.21B1.7B1.56B
Short-term Investments1.04B1.88B1.79B1.57B0
Net Receivables198.7M220.4M278.9M279.3M350.2M
Inventory93.8M102M111.8M157.9M183.1M
Other Current Assets100.4M219.2M166.2M169.7M1.61B
Total Current Assets2.32B3.38B3.55B3.87B3.7B
Property, Plant & Equipment (Net)780.9M861.5M1.05B1.22B1.73B
Goodwill28M28M33.7M32.3M0
Intangible Assets16.6M16.5M80.5M79.6M116.5M
Long-term Investments1.65B1.32B1.91B1.48B1.78B
Tax Assets261.9M327.7M394.8M458.4M357.7M
Other Non-current Assets108.2M114.3M151.8M222.1M196.9M
Total Non-current Assets2.85B2.66B3.62B3.49B4.18B
Total Assets5.17B6.04B7.17B7.36B7.88B
Account Payables3.8M4.1M5.6M6M7.1M
Short-term Debt00400M300M0
Tax Payables00000
Deferred Revenue00000
Other Current Liabilities248M13M40.5M432.1M39.3M
Total Current Liabilities305.4M343.2M804.4M738.1M560.6M
Long-term Debt800M800M300M00
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities104.8M104.6M77.8M181.9M192.9M
Total Non-current Liabilities904.8M904.6M377.8M181.9M223.2M
Total Liabilities1.21B1.25B1.18B920M783.8M
Common Stock700K700K700K800K800K
Retained Earnings4.32B5.04B6.03B7.22B8.56B
Accumulated OCI(23M)(55.5M)(12.8M)(3.4M)900K
Other Stockholders Equity00000
Minority Interest00000
Total Equity3.96B4.8B5.98B6.44B7.1B
Total Debt800M800M700M300M37.6M
Net Debt(94.8M)(161.2M)(507.7M)(1.4B)(1.52B)

United Therapeutics Corporation

NASDAQ:UTHR

Intrinsic Alpha fair value

Locked

Current Price

$577.34

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.